Academic Grants & Research
Filter News
Found 2,921 articles
-
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
11/20/2023
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the closing of its license agreements with the Icahn School of Medicine at Mount Sinai, in New York, NY, to develop and commercialize electrocardiographic AI algorithms and assets.
-
HSS (Hospital for Special Surgery) to Harness Surge in Artificial Intelligence Applications and Democratize High Quality Healthcare
11/16/2023
Hospital for Special Surgery, the world's leading musculoskeletal health institution, has received support from Schmidt Futures to advance its research and development efforts in artificial intelligence and machine learning.
-
University of Tsukuba and Astellas Confirm a Strategic Partnership
11/16/2023
University of Tsukuba and Astellas Pharma Inc. announced that they have signed a letter of confirmation regarding a strategic partnership to accelerate the digitalization of the drug discovery research field, as well as the development of the life science ecosystem in Tsukuba and Kashiwa-no-ha, and to further accelerate innovative drug discovery research and development.
-
Halberd Corporation Plans to Extend Research Partnership with Mississippi State University
11/15/2023
Halberd Corporation is in talks with Mississippi State University to extend its original six-month research arrangement by an additional two years, encompassing yet-to-be defined projects.
-
HSS Researchers Enable Study Identifying Subtypes of Rheumatoid Arthritis
11/15/2023
A new study published in Nature, conducted by the Accelerating Medicines Partnership, reports on the identification of new subtypes of rheumatoid arthritis by analyzing molecular patterns in biopsies from patient joints.
-
University of Basel Delivers First Biological Implants for Treatment of Cartilage Lesions and Osteoarthritis in Humans
11/15/2023
The Department of Biomedicine at the University of Basel and the University Hospital Basel, announced that it delivered the first surgical procedure to treat Osteoarthritis in humans.
-
HSS Presents New Reproductive Health Research at the ACR Convergence 2023
11/14/2023
At this year's American College of Rheumatology annual meeting, Hospital for Special Surgery presented a number of important studies focused on reproductive health for patients with systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases, including issues related to fertility, sexual function, use of contraception and HPV vaccination.
-
BioVAT-HF Phase 1/2 Reveals First Evidence for Effective Heart Repair in Advanced Heart Failure
11/14/2023
Repairon together with the University Medical Center Göttingen and Lübeck as well as the German Center for Cardiovascular Research, announced that its Co-Founder Professor Wolfram Zimmermann held a Featured Science presentation at the American Heart Association Scientific Sessions 2023 on November 12, 2023, in Philadelphia, US.
-
Study Finds People with Inflammatory Arthritis Face Significant Psychological Challenges in Maintaining Employment
11/13/2023
Research from Hospital for Special Surgery reveals a significant psychological impact related to inflammatory arthritis patients' efforts to maintain employment while coping with the challenges of their illness.
-
New Study Shows Perception of Aging is Linked to Level of Physical Activity in Arthritis Patients
11/13/2023
People with arthritis who report more negative feelings about how they are aging tend to get less physical activity and perceive themselves as less healthy, according to a new study by researchers at Hospital for Special Surgery and Weill Cornell Medicine.
-
HSS Research Shows Obesity Is Associated with Worse Flare Symptoms and Quality of Life in People with Early Rheumatoid Arthritis
11/12/2023
A recent study from Hospital for Special Surgery and others has found a correlation between obesity and more severe disease flare symptoms that negatively affect quality of life in patients with early rheumatoid arthritis, a systemic, autoimmune, inflammatory disorder affecting multiple joints in the body.
-
A recent report by Tufts Medical Center reveals impressive approval rates for durable cell and gene therapies, but experts urge caution over persistent safety and accessibility concerns.
-
BioMed X and AbbVie Start New Research Project in the USA
10/31/2023
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.
-
Breathing new life into patient care: Innovative partnership aims to transform interstitial lung disease support
10/25/2023
In a unique partnership, Boehringer Ingelheim Ltd., St. Joseph's Healthcare Hamilton, and McMaster University have come together to transform the way patients are supported at the onset of a diagnosis related to interstitial lung disease.This collaboration marks a significant leap forward in patient-centric care, driven by empathy and understanding.
-
NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
10/24/2023
NexImmune, Inc. announces the extension of the research partnership between NexImmune, Yale and JDRF to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb to tolerize, deplete or modulate diabetes antigen-specific T cells.
-
AI and machine learning could transform drug discovery, but first, practitioners must overcome ethical challenges en route to medicines for all.
-
Leading Academic Medical Center Performs First Heart Transplant in the U.S. Utilizing NIHP Technology as Part of XVIVO's PRESERVE Clinical Trial
10/23/2023
XVIVO Perfusion AB On October 14, 2023 Duke University Hospital in Durham, N.C., performed the first heart transplant in the U.S. using XVIVO's Non-Ischemic Heart Preservation device and solution as part of the PRESERVE clinical trial: A Prospective, Multi-center, Single-Arm, Open-Label Study of Hearts Transplanted after Non-Ischemic Heart PRESERVation from Extended Donors.
-
Biotech Accelerator Debuts in Houston
10/19/2023
The new Rice Biotech Launch Pad aims to harness local resources to grease the skids of innovation, from the lab to the clinic. -
NUS scientists develop innovative magnetic gel that heals diabetic wounds three times faster
10/19/2023
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal.
-
Semarion Announces Early Adopter Programme for SemaCyte Microcarrier Platform
10/18/2023
Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced the opening of its Early Adopter Programme for its SemaCyte® Microcarrier Platform.